Alset International Ltd., an investment holding company, engages in the property development, information technology (IT), biomedical, and investment businesses in Singapore, Australia, the United States, and the People's Republic of China. The company develops property projects; and invests in property development projects. It is also involved in the research and development of IT hardware and software, such as customizable and robust open platform with a focus on providing business-to-business solutions, such as enterprise communications and workflow; and provision of IT-related services to end-users, service providers, and other commercial users through multiple platforms, as well as energy saving business. In addition, the company trades in quoted securities, commodities, and other derivatives and financial products; invests in various quoted and unquoted securities, such as investments ranging from pre-initial public offer investment, various forms of capital in companies, and funds with business growth and trade sale; undertakes businesses in incubation and angel investment; and offers corporate strategy and business development advisory services. Further, it develops, researches, tests, manufactures, licenses, and distributes biomedical products. Additionally, the company offers portfolio management and investment advisory services; and sells, markets, and supports mobile applications, as well as distributes health supplements. The company was formerly known as Singapore eDevelopment Limited and changed its name to Alset International Ltd. in September 2020. Alset International Ltd. was incorporated in 2009 and is based in Singapore. Alset International Ltd.is a subsidiary of Hengfai Business Development Pte. Ltd.